Prism 301-A Phase 3, Open-Label, Randomized, Multi-Center Study to Assess the Safety and Tolerability of an Induction, Titration, and Maintenance Dose Regimen of BMN 165 Self Administered by Adults with Phenylketonuria Not Previously Treated with BMN 165

  • Amato, Ralph (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date1/31/1412/31/16